Cargando…

Comparison of Commercially Available and Laboratory-Developed Assays for In Vitro Detection of SARS-CoV-2 in Clinical Laboratories

Multiple laboratory-developed tests (LDTs) and commercially available assays have emerged to meet diagnostic needs related to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. To date, there is limited comparison data for these different testing platforms. We compared the an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lieberman, Joshua A., Pepper, Gregory, Naccache, Samia N., Huang, Meei-Li, Jerome, Keith R., Greninger, Alexander L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2020
Materias:	Virology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383518/ https://www.ncbi.nlm.nih.gov/pubmed/32350048 http://dx.doi.org/10.1128/JCM.00821-20

Ejemplares similares

Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratories
por: Stein, Derek R., et al.
Publicado: (2021)

Comparative Performance of SARS-CoV-2 Detection Assays Using Seven Different Primer-Probe Sets and One Assay Kit
por: Nalla, Arun K., et al.
Publicado: (2020)

Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detection
por: Bond, K.A., et al.
Publicado: (2021)

Increasing the Efficiency of a National Laboratory Response to COVID-19: a Nationwide Multicenter Evaluation of 47 Commercial SARS-CoV-2 Immunoassays by 41 Laboratories
por: van den Beld, Maaike J. C., et al.
Publicado: (2021)

Comparison of Two Commercial Molecular Tests and a Laboratory-Developed Modification of the CDC 2019-nCoV Reverse Transcriptase PCR Assay for the Detection of SARS-CoV-2
por: Moore, Nicholas M., et al.
Publicado: (2020)

Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers
por: Patel, Eshan U., et al.
Publicado: (2021)

Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens
por: Hogan, Catherine A., et al.
Publicado: (2020)

Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate
por: Addetia, Amin, et al.
Publicado: (2020)

Sensitivity of Detection and Variant Typing of SARS-CoV-2 in European Laboratories
por: Mögling, Ramona, et al.
Publicado: (2022)

Comparison of FilmArray Respiratory Panel and laboratory-developed real-time reverse transcription–polymerase chain reaction assays for respiratory virus detection()()
por: Renaud, Christian, et al.
Publicado: (2012)

Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories
por: Harritshøj, Lene H., et al.
Publicado: (2021)

Evaluation of serological assays available in a biosafety level 2 laboratory and their application for survey of Middle East respiratory syndrome coronavirus among livestock in Ethiopia
por: TERAMICHI, Takurou, et al.
Publicado: (2019)

Comparing Immunoassays for SARS-CoV-2 Antibody Detection in Patients with and without Laboratory-Confirmed SARS-CoV-2 Infection
por: Leuzinger, Karoline, et al.
Publicado: (2021)

Evaluation of Three Commercial SARS-CoV-2 Serologic Assays and Their Performance in Two-Test Algorithms
por: Turbett, Sarah E., et al.
Publicado: (2020)

Divergence of wastewater SARS-CoV-2 and reported laboratory-confirmed COVID-19 incident case data coincident with wide-spread availability of at-home COVID-19 antigen tests
por: Boehm, Alexandria B., et al.
Publicado: (2023)

Limited Marginal Utility of Deep Sequencing for HIV Drug Resistance Testing in the Age of Integrase Inhibitors
por: Dalmat, Ronit R., et al.
Publicado: (2018)

Analytical Sensitivity of the Abbott BinaxNOW COVID-19 Ag Card
por: Perchetti, Garrett A., et al.
Publicado: (2021)

Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens
por: Zhen, Wei, et al.
Publicado: (2020)

Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays
por: Sholukh, Anton M., et al.
Publicado: (2021)

Retrospective clinical evaluation of 4 lateral flow assays for the detection of SARS-CoV-2 IgG
por: McAulay, Kathrine, et al.
Publicado: (2020)

Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 Detection
por: Visseaux, Benoit, et al.
Publicado: (2020)

Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
por: Valcourt, Emelissa J., et al.
Publicado: (2021)

External Quality Assessment of SARS-CoV-2 Sequencing: an ESGMD-SSM Pilot Trial across 15 European Laboratories
por: Wegner, Fanny, et al.
Publicado: (2022)

Evaluation of Commercial Anti-SARS-CoV-2 Antibody Assays and Comparison of Standardized Titers in Vaccinated Health Care Workers
por: Saker, Kahina, et al.
Publicado: (2022)

Early Laboratory Diagnosis of COVID-19 by Antigen Detection in Blood Samples of the SARS-CoV-2 Nucleocapsid Protein
por: Thudium, Rebekka F., et al.
Publicado: (2021)

Analysis of sputum/tracheal aspirate and nasopharyngeal samples for SARS-CoV-2 detection by laboratory-developed test and Panther Fusion system
por: Thwe, Phyu M., et al.
Publicado: (2021)

Proficiency testing for SARS-CoV-2 in assuring the quality and overall performance in viral RNA detection in clinical and public health laboratories
por: Lau, Katherine A., et al.
Publicado: (2022)

Variable Sensitivity of SARS-CoV-2 Molecular Detection in European Expert Laboratories: External Quality Assessment, June and July 2020
por: Fischer, Carlo, et al.
Publicado: (2021)

A Recurrent Mutation at Position 26340 of SARS-CoV-2 Is Associated with Failure of the E Gene Quantitative Reverse Transcription-PCR Utilized in a Commercial Dual-Target Diagnostic Assay
por: Artesi, Maria, et al.
Publicado: (2020)

Evaluation of Six Commercial Mid- to High-Volume Antibody and Six Point-of-Care Lateral Flow Assays for Detection of SARS-CoV-2 Antibodies
por: Charlton, Carmen L., et al.
Publicado: (2020)

Virucidal Effect of Commercially Available Disinfectants on Equine Group A Rotavirus
por: NEMOTO, Manabu, et al.
Publicado: (2014)

Comparison of ePlex Respiratory Pathogen Panel with Laboratory-Developed Real-Time PCR Assays for Detection of Respiratory Pathogens
por: Nijhuis, R. H. T., et al.
Publicado: (2017)

Comparison of an ID NOW COVID-19 Assay Used at the Point of Care to Laboratory-Based Nucleic Acid Amplification Tests
por: Payne, David, et al.
Publicado: (2023)

Multi-center clinical evaluation of the Panther Fusion SARS-CoV-2/Flu A/B/RSV assay in nasopharyngeal swab specimens from symptomatic individuals
por: Sasidharan, Anjana, et al.
Publicado: (2023)

Clinical Performance and Trends during the First Two Months of Monkeypox Virus PCR Testing at Two United States Reference Labs
por: Lieberman, Nicole A. P., et al.
Publicado: (2022)

Evaluation of multiple commercial molecular and conventional diagnostic assays for the detection of respiratory viruses in children
por: Gharabaghi, F., et al.
Publicado: (2011)

Impact of SARS-CoV-2 Variants on the Analytical Sensitivity of rRT-PCR Assays
por: Chen, Yuqing, et al.
Publicado: (2022)

Direct Comparison of SARS-CoV-2 Analytical Limits of Detection across Seven Molecular Assays
por: Fung, Becky, et al.
Publicado: (2020)

How many are we missing with ID NOW COVID-19 assay using direct nasopharyngeal swabs? Findings from a mid-sized academic hospital clinical microbiology laboratory
por: Thwe, Phyu M., et al.
Publicado: (2020)

Evaluation of Diagnostic Accuracy of Eight Commercial Assays for the Detection of Rubella Virus-Specific IgM Antibodies
por: Hiebert, Joanne, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u9po40li0t8kkvarh0prkect0m